Garth Cumberlidge

Garth Cumberlidge has an extensive and successful history in the pharmaceutical industry. Garth is currently the President, Director, and CEO of Semathera. Prior to this, they served as the Chairman of the Board at EYEVENSYS from March 2017 to March 2020. From January 2005 to December 2017, they were the President, Director, and Chief Executive Officer of Mimetogen Pharmaceuticals. From January 1998 to December 2004, they were the President and Chief Executive Officer of Qbiogene. And from January 1994 to December 1998, they were the Vice President of Biomedical Research Products at ICN Pharmaceuticals. Throughout their career, Garth has demonstrated their ability to lead and grow companies in the ever-changing landscape of the pharmaceutical industry.

Some direct reports include Véronique Bougie - COO, Mike Sapieha - Founder & Chief Scientific Officer.